期刊文献+

丝氨酸/苏氨酸蛋白激酶对肝癌细胞凋亡的促进作用 被引量:7

HIPK1 induced hepatoma cell apoptosis
原文传递
导出
摘要 目的评价丝氨酸/苏氨酸蛋白激酶(HIPK1)促进肿瘤坏死因子(TNF)-α诱导的JNK/p38激活及其对肝癌细胞凋亡的影响。方法Hepa1-6细胞,分别感染重组腺病毒rAd-Lacz-V5(107PFU/孔)和rAd-myc-HIPK1(107PFU/孔)48h,荧光显微镜检测Lacz和HIPK1的蛋白表达,TNF-α处理细胞后Western blot检测JNK/p38激活情况;HIPK1的RNA干扰检测HIPK1在JNK/p38激活中的作用;TNF-α处理病毒感染的Hepa1-6细胞24h,DAPI染色荧光显微镜下了解细胞凋亡情况。结果荧光显微镜下见Lacz和HIPK1蛋白在Hepa1-6细胞中表达效率高;HIPK1组中TNF-α介导的磷酸化型JNK/p38的表达明显高于Lacz组,相反HIPK1的RNA干扰组中TNF-α介导的磷酸化型JNK/p38的表达明显低于对照组;细胞核形态学检测HIPK1组中细胞凋亡率为(30.72±5.67)%,而Lacz组为(9.82±3.41)%,两组间差异有统计学意义(P<0.01)。结论HIPK1促进TNF-α介导的JNK/p38的激活并诱导肝癌细胞Hepa1-6凋亡。 Objectibve To assess the role of HIPK1 on TNF-α- induced JNK/p38 activation and hepatoma cell apoptosis. Methods Hepal-6 cells were infected with rAd-Lacz-V5 (101 PFU/well) and rAd-myc-HIPK1 (101 PFU/weU), respectively. Forty-eight h later, the expression of protein Laez and HIPK1 was detected by immunoflouresenee. After the cells were treated with TNF-α, Western blotting was used to detect the phosphorylation of JNK/p38. Moreover, HIPK1 was knockdown by RNA interference in Hepa1-6 cells and the cells were treated with TNF-α, and phosphorylation of JNK/p38 in those cells was checked by Western blotting. The morphology of nuclei in each group was revealed by DIPA staining. Results Over-expression of HIPK1 increased the TNF-α-indueed JNK/p38 activation, whereas small interference RNA of HIPK1 decreased the TNF-α-indueed JNK/p38 activation. Consistently, the percentage of apoptotie cells in HIPK1 group was (30.72 ± 5.67) %, but (9.82±3.41) % in Lacz group (P〈0.01). Conclusion HIPK1 enhances the TNF-α-indueed JNK/p38 activation and promotes the apoptosis of Hepal-6 hepatoma cells.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2006年第1期55-56,共2页 Chinese Journal of Experimental Surgery
关键词 丝氨酸蛋白激酶 苏氨酸蛋白激酶 肝癌 细胞凋亡 肿瘤细胞 细胞核形态 p38 Carcinoma, hepaticulla Apoptosis TNF-α
  • 相关文献

参考文献2

二级参考文献9

  • 1Wiley SR,Schooley K,Smolak PJ,et al.Identification and characterization of a new member of the TNF family that induces apoptosis.Immunity,1995,3:673-682.
  • 2Walczak H,Miller RE,Ariail K,et al.Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.Nat Med,1999,5:157-163.
  • 3Sedger LM,Glaccum MB,Schuh JC,et al.Characterization of the in vivo function of TNF-alpha-related apoptosis-inducing ligand,TRAIL/Apo2L,using TRAIL/Apo2L gene-deficient mice.Eur J Immunol,2002,32:2246-2254.
  • 4Qian Q,Sham J,Che X,et al.Gene-viral vectors:a promising way to target tumor cells and express anticancer genes simultaneously.Chin Med J (Engl),2002,115:1213-1217.
  • 5Ashkenazi A,Pai RC,Fong S,et al.Safety and antitumor activity of recombinant soluble Apo2 ligand.J Clin Invest,1999,104:155-162.
  • 6Jo M,Kim TH,Seol DW,et al.Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand.Nat Med,2000,6:564-567.
  • 7Lawrence D,Shahrokh Z,Marsters S,et al.Differential hepatocyte toxicity of recombinant Apo2L/TRAIL versions.Nat Med,2001,7:383-385.
  • 8Kagawa S,He C,Gu J,et al.Antitumor activity and bystander effects of the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) gene.Cancer Res,2001,61:3330-3338.
  • 9Russell WC.Update on adenovirus and its vectors.J Gen Virol,2000,81:2573-2604.

共引文献2

同被引文献70

引证文献7

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部